Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
Recruiting now · Not applicable
Conditions studied: Atrial Fibrillation
In brief
The purpose of this study is to provide clinical data pertaining to the safety and performance of the Globe Mapping and Pulsed Field Ablation System for treating subjects with atrial fibrillation (AF).
Key facts
- Study ID
- NCT05164107
- Run by
- Kardium Inc.
- People needed
- 175
- Starts
- 2021-12-08
- Expected to finish
- 2027-05-01
- Last updated by the study team
- 2026-01-30
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Motol and Homolka University Hospital — Prague, Czechia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.